Lo-Ciganic WH - Search Results

1

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM. Cochran G, et al. Med Care. 2017 Mar;55(3):291-298. doi: 10.1097/MLR.0000000000000676. Med Care. 2017. PMID: 27984346 Free PMC article.

2

Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016.

Keshwani S, Smith SM, Brown J, Lo-Ciganic WH, Yang S, Smolinski NE, Hincapie-Castillo JM. Keshwani S, et al. J Pain. 2023 Nov;24(11):1994-2002. doi: 10.1016/j.jpain.2023.06.008. Epub 2023 Jun 15. J Pain. 2023. PMID: 37330160

3

Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.

Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Park H, et al. Sci Rep. 2022 Oct 27;12(1):18094. doi: 10.1038/s41598-022-22819-4. Sci Rep. 2022. PMID: 36302828 Free PMC article.

4

Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults.

Lo-Ciganic WH, Boudreau RM, Gray SL, Zgibor JC, Donohue JM, Perera S, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Hanlon JT. Lo-Ciganic WH, et al. Ann Pharmacother. 2013 Jul-Aug;47(7-8):984-92. doi: 10.1345/aph.1S050. Epub 2013 Jun 18. Ann Pharmacother. 2013. PMID: 23780807 Free PMC article. Clinical Trial.

5

Statin use and decline in gait speed in community-dwelling older adults.

Lo-Ciganic WH, Perera S, Gray SL, Boudreau RM, Zgibor JC, Strotmeyer ES, Donohue JM, Bunker CH, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Caserotti P, Harris T, Shorr RI, Hanlon JT; Health, Aging and Body Composition Study. Lo-Ciganic WH, et al. J Am Geriatr Soc. 2015 Jan;63(1):124-9. doi: 10.1111/jgs.13134. Epub 2014 Dec 23. J Am Geriatr Soc. 2015. PMID: 25537649 Free PMC article.

6

Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Cochran G, et al. Subst Abus. 2015;36(2):192-202. doi: 10.1080/08897077.2014.993491. Epub 2015 Feb 11. Subst Abus. 2015. PMID: 25671499 Free PMC article. Review.

7

Using machine learning to examine medication adherence thresholds and risk of hospitalization.

Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Lo-Ciganic WH, et al. Med Care. 2015 Aug;53(8):720-8. doi: 10.1097/MLR.0000000000000394. Med Care. 2015. PMID: 26147866 Free PMC article.

8

Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.

Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Gordon AJ, et al. J Addict Med. 2015 Nov-Dec;9(6):470-7. doi: 10.1097/ADM.0000000000000164. J Addict Med. 2015. PMID: 26517324

9

Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.

Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM. Lo-Ciganic WH, et al. Addiction. 2016 May;111(5):892-902. doi: 10.1111/add.13270. Epub 2016 Jan 30. Addiction. 2016. PMID: 26662858

10

Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Lo-Ciganic WH, Gellad WF, Huskamp HA, Choudhry NK, Chang CC, Zhang R, Jones BL, Guclu H, Richards-Shubik S, Donohue JM. Lo-Ciganic WH, et al. Med Care. 2016 Jul;54(7):725-32. doi: 10.1097/MLR.0000000000000549. Med Care. 2016. PMID: 27116109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page